Doseology Launches Feed That Brain(TM) Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot

Executive Summary

• Doseology Sciences Inc. launched the Feed That Brain® Energy Pouches in the United States as part of a direct‑to‑consumer pilot program.
• The nicotine‑free, caffeine‑based oral pouches are now available at feedthatbrain.com and Amazon.com, marking the company’s first U.S. consumer rollout.
• The Company granted 140,000 restricted share units (RSUs) and 210,000 performance share units (PSUs) to a director, with RSUs vesting monthly over 36 months and PSUs tied to defined performance milestones.

Key Details

• Product: Feed That Brain® Energy Pouches – clean‑energy oral pouch format, nicotine‑free, caffeine‑based, sugar‑free.
• Availability: Direct‑to‑consumer pilot in the U.S.; purchasable at feedthatbrain.com and Amazon.com.
• Strategic Goal: Validate oral‑pouch delivery as a scalable stimulant platform; assess consumer adoption, usage frequency, and repeat purchase behavior, especially among underserved demographics seeking alternatives to traditional energy drinks.
• Executive Quote: Larry Latowsky, Executive Chairman – “This U.S. pilot is a disciplined and deliberate step in Doseology’s strategy to build a scalable oral stimulant platform.”
• Equity Compensation:
• 140,000 RSUs granted to a director; vesting equal monthly installments over 36 months from grant date.
• 210,000 PSUs granted to the same director; vest upon achievement of defined performance milestones.
• Market Context: Highlights growing consumer acceptance of discreet oral‑pouch formats and aligns with broader trends in portable, non‑nicotine stimulant products.

Notable Quotes

“Feed That Brain demonstrates how controlled, non‑nicotine energy delivery can meet evolving consumer preferences while generating the operational insight required for responsible growth.” – Larry Latowsky, Executive Chairman, Doseology Sciences Inc.